Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Chronic Lymphocytic Leukemia

Breast Cancer

Gastrointestinal Cancer

Chronic Lymphocytic Leukemia

FDA Grants Duvelisib Priority Review for CLL and Follicular Lymphoma

The FDA has granted a priority review to a new drug application for duvelisib for a full approval for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma and an accelerated approval for the treatment...
Read More >>

Expert Reviews CLL Advances Presented at ASH

Venetoclax/Rituximab Positive PFS Data Published in NEJM

CLL Expert Explains Latest Treatment Developments in the Field

Ibrutinib, Venetoclax, and Obinutuzumab Triplet Safe, Effective as Initial CLL Therapy

Davids Discusses Frontline CLL Combo of Ibrutinib Plus Chemoimmunotherapy

View More Stories >>

View Conference Coverage

2018 AACR Annual Meeting

2018 European Lung Cancer Congress

2018 SGO Annual Meeting

2018 State of the Science Summit on Gastrointestinal Malignancies

2018 State of the Science Summit on Prostate Cancer

Dr. Kay Discusses Combination Strategies in CLL

Dr. Byrd on Challenges Facing CLL

Dr. Skarbnik on the Role of Chemotherapy in CLL

Dr. Barrientos Discusses Acalabrutinib in CLL

Dr. Kay Discusses the Role of Ibrutinib in CLL

Dr. Byrd Discusses the Future Treatment of CLL

Dr. Logan Discusses Acalabrutinib in CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Evaluating CAR T-Cell Therapy Use

The Role of Transplant and Future of CLL

Other Promising Strategies in CLL

Maintenance and Frontline Therapy in CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Impact of Prognostic Factors on Clinical Decisions in CLL

Other Prognostic Factors in Chronic Lymphocytic Leukemia

TP53 and Deletion 17p as Prognostic Factors in CLL

The Value of MRD Testing in Lymphoid Malignancies

Considering the Value of PI3 Kinase Inhibitors in FL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Other Promising Strategies in CLL

This expert panel discussion led by William Wierda, MD, focuses on promising strategies available for the treatment of chronic lymphocytic leukemia. Dr. Wierda is joined in this discussion by Steven Coutre, MD; Matthew S. Davids, MD, MMSc; Nicole Lamanna, MD; and Shuo Ma, MD, PhD.

View Now

The Use of Novel PI3K Inhibitors in CLL

In this segment William Wierda, MD, PhD, leads a panel discussion regarding the use of novel PI3K inhibitors in chronic lymphocytic leukemia.

View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More